Fundz

VahatiCor secures $23 million in Series B funding led by S3 Ventures to enhance A-FLUX® development for coronary microvascular dysfunction.

PRIVATENov 18, 2025

Amount Raised

$23 Million

Round Type

Series B

Santa ClaraBiotechnologyHealth CareMedicalTherapeutics

Investors

Intuitive VenturesS3 Ventures

Description

VahatiCor has closed an oversubscribed $23 million Series B financing round. This funding led by S3 Ventures will aid in advancing the SERRA-I feasibility study and subsequent regulatory preparations. The new capital will support ongoing engineering development and pivotal trials. VahatiCor aims to enhance treatment options for millions suffering from coronary microvascular dysfunction.

Quick answer

VahatiCor raised $23 Million in a Series B round, dated November 18, 2025. Investors: Intuitive Ventures and S3 Ventures. VahatiCor is based in Santa Clara, California, United States.

How much did VahatiCor raise?
VahatiCor raised $23 Million in a Series B round on November 18, 2025.
Who invested in VahatiCor?
Intuitive Ventures and S3 Ventures are named as investors in this round.
What does VahatiCor do?
VahatiCor is a medtech company dedicated to transforming cardiac care for Coronary Microvascular Dysfunction (CMD).
Where is VahatiCor based and how big is it?
VahatiCor is based in Santa Clara, California, United States. Fundz records about 15 employees.
Who are the decision-makers at VahatiCor?
Fundz holds 1 contact at VahatiCor. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as VahatiCor that raised within 45 days of this round, from Fundz verified event records.

  • MAIA Biotechnology raised $1.5M on December 22, 2025.
  • Tivic raised $12M on December 10, 2025.
  • Tivic raised $16M on December 10, 2025.
  • Citius Oncology raised $18M (Funding Round) on December 9, 2025.
  • Aethlon Medical raised $2.2M on December 8, 2025.
  • Santersus AG raised an undisclosed amount (Series A) on December 1, 2025.

Who to call at VahatiCor, and when

A new round usually means VahatiCor is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day VahatiCor raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at VahatiCor, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at VahatiCor. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

VahatiCor

Location

Santa Clara, California, United States

About

VahatiCor is a medtech company dedicated to transforming cardiac care for Coronary Microvascular Dysfunction (CMD). They are focused on developing innovative therapies, particularly the A-FLUX Reducer System®, which aims to enhance myocardial perfusion and relieve symptoms of angina for millions affected by CMD. The company is currently advancing clinical studies and preparing for pivotal trials to bring their breakthrough therapies to market. Their mission is to improve the quality of life for patients suffering from this often overlooked medical condition.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment VahatiCor raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for VahatiCor's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

VahatiCor raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.